Stock Evaluator: Sera Prognostics, Inc. (SERA)

Sera Prognostics, Inc. SERA

$1.84 -0.06 -2.91%
November 20, 2026 2:53:22 PM EST November 10, 2021 Volume: 7,234
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Commentary & Analysis


Financial Summary

Share Statistics SERA Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $75.2 $212.8 20%
Shares Out (Mil) 50.8 55.2 48%
Institutional Ownership 89.8% 93.3% 57%
Float (Mil) 28.0 40.8 34%
Beta 1.14 1.03 67%
Avg Daily Volume (000s) 55 559 30%
Price Change
(52-week)
(39.4%) 40.3% 26%
Growth SERA Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.6% na
Net Income (5yr) (10.0%) (10.5%) 29%
EPS (5yr) 44.5% 15.4% 91
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 14.9% (15.7%) 72%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS ($0.163) ($0.660) ($0.570)
Month Ago EPS ($0.170) ($0.658) ($0.535)
# Rev Up 1 1 1
# Rev Down 0 0 0
Three Months Ago EPS ($0.170) ($0.658) ($0.535)
Year/Year Chg 2.5% (1.5%) (22.4%)
Financials SERA Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $40 na
Net Income (TTM) (Mil) ($34) ($44) 19%
EPS (TTM) ($0.664) ($1.400) 24%
Operating Cash Flow (TTM) (Mil) ($29) ($34) 13%
Net Cash Flow (TTM) (Mil) $-0 $-0 44%
Long-Term Debt (Q1) (Mil) $3 $4 22%
Enterprise Value (Q1) (Mil) $9 $142 8%
Valuation SERA Industry
Median
Percentile
(All Stocks)
P/B 1.43 1.97 44%
P/E na 16.8 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 0.8 na
Ratios SERA Industry
Median
Percentile
(All Stocks)
Gross Margin (103.1%) 67.6% 2%
Net Margin na (50.8%) na
ROA (35.6%) (47.4%) 14%
ROE (49.7%) (51.4%) 15%
Liabilities to Assets 34.4% 29.6% 25%
F-Score 4 3 34%

Sera Prognostics, Inc. did not pass any screens on 11/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors